Onconetix (FRA:J4T) Institutional Ownership: 0.19% (As of Aug. 10, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:J4T Onconetix Inc FRA:J4T
19 GF Score
Price €11,985.00
! 4 Warning Signs
View Full Analysis

What is Onconetix Institutional Ownership?

Onconetix FRA:J4T 19 Institutional Ownership is 0.19% as of Aug. 10, 2026. GuruFocus rates FRA:J4T with a GF Score™ of 19/100. The stock has 4 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Onconetix's institutional ownership is 0.19%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Onconetix's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Onconetix's Float Percentage Of Total Shares Outstanding is 100.04%.

Onconetix Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Onconetix's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Onconetix Institutional Ownership Chart

Onconetix Historical Data

The historical data trend for Onconetix can be seen below:

2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31
Institutional Ownership 1.01 1.01 1.15 1.20 0.79 3.80 3.80 3.80 0.03 0.19
FRA:J4T
19GF Score
Onconetix Inc FRA:J4T
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Onconetix Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.19% mean?
Onconetix (FRA:J4T) has a Institutional Ownership of 0.19% as of Aug. 10, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Onconetix and its competitors.
Is Onconetix's Institutional Ownership too high?
Onconetix's current Institutional Ownership is 0.19%. Overall, Onconetix has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Onconetix's Institutional Ownership compare to SPRC and ACUT?
Onconetix's Institutional Ownership of 0.19% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Onconetix and its competitors. Onconetix's current Institutional Ownership is 0.19%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Onconetix stock overvalued right now?
Onconetix (FRA:J4T) has a current Institutional Ownership of 0.19%. The current Institutional Ownership is 0.19%. Onconetix's overall GF Score™ is 19/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Onconetix (FRA:J4T), the current Institutional Ownership is 0.19% as of Aug. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Onconetix Business Description

Other Exchanges ONCO:USA
Address 201 E. Fifth Street, Suite 1900, Cincinnati, OH, USA, 45202
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. The company owns Proclarix, an in vitro diagnostic test for prostate cancer, approved for sale in the European Union. Additionally, it is focused on marketing Proclarix in the U.S. as a lab-developed product. Onconetix operates in one segment: commercial. Geographically, the company generates maximum revenue from Switzerland and the rest from the United Kingdom.
19GF Score

Get the complete analysis for FRA:J4T

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€11,985.00
Price